Pectin has been demonstrated to stimulate the release of GLP-1 (glucagon-like peptide-1), which can be employed in the treatment or prevention of metabolic syndrome, diabetes, and obesity (30). The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.